 Csaba Galambos
Concepts (481)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Alveoli | 16 | 2023 | 365 | 2.930 |
Why?
| | Persistent Fetal Circulation Syndrome | 10 | 2023 | 136 | 2.780 |
Why?
| | Lung | 31 | 2024 | 3745 | 2.540 |
Why?
| | Respiratory Insufficiency | 6 | 2023 | 311 | 2.410 |
Why?
| | Pulmonary Artery | 11 | 2021 | 1030 | 2.360 |
Why?
| | Pulmonary Veins | 5 | 2019 | 93 | 1.790 |
Why?
| | Arteriovenous Anastomosis | 4 | 2022 | 13 | 1.690 |
Why?
| | Bronchial Arteries | 3 | 2018 | 12 | 1.680 |
Why?
| | Bronchi | 6 | 2023 | 241 | 1.520 |
Why?
| | Hypertension, Pulmonary | 17 | 2024 | 1747 | 1.480 |
Why?
| | Pulmonary Circulation | 7 | 2022 | 417 | 1.260 |
Why?
| | Glycogen Storage Disease | 4 | 2021 | 19 | 1.170 |
Why?
| | Down Syndrome | 6 | 2021 | 469 | 1.150 |
Why?
| | Infant, Newborn | 37 | 2024 | 5688 | 1.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2023 | 183 | 1.050 |
Why?
| | T-Box Domain Proteins | 3 | 2023 | 96 | 1.020 |
Why?
| | Lung Diseases | 9 | 2024 | 713 | 1.020 |
Why?
| | Immunohistochemistry | 13 | 2017 | 1663 | 1.020 |
Why?
| | Infant | 38 | 2025 | 8912 | 1.000 |
Why?
| | Homeodomain Proteins | 4 | 2017 | 489 | 1.000 |
Why?
| | Lung Diseases, Interstitial | 6 | 2021 | 592 | 0.940 |
Why?
| | Bronchopulmonary Dysplasia | 3 | 2024 | 374 | 0.930 |
Why?
| | Abnormalities, Multiple | 3 | 2016 | 178 | 0.930 |
Why?
| | Heart Defects, Congenital | 6 | 2022 | 747 | 0.870 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 3 | 2014 | 56 | 0.850 |
Why?
| | Lymphatic Vessels | 3 | 2009 | 60 | 0.830 |
Why?
| | Germ-Line Mutation | 1 | 2023 | 138 | 0.810 |
Why?
| | Cardiovascular Abnormalities | 1 | 2022 | 14 | 0.790 |
Why?
| | Sudden Infant Death | 1 | 2022 | 27 | 0.790 |
Why?
| | Capillaries | 3 | 2014 | 91 | 0.750 |
Why?
| | Humans | 91 | 2025 | 128019 | 0.700 |
Why?
| | Graft Rejection | 5 | 2013 | 557 | 0.650 |
Why?
| | Tumor Suppressor Proteins | 3 | 2011 | 313 | 0.640 |
Why?
| | Mutation | 12 | 2023 | 3682 | 0.640 |
Why?
| | Histological Techniques | 2 | 2009 | 39 | 0.630 |
Why?
| | Death, Sudden | 1 | 2019 | 24 | 0.630 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 142 | 0.620 |
Why?
| | Child, Preschool | 25 | 2021 | 10378 | 0.620 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 87 | 0.610 |
Why?
| | Fatal Outcome | 7 | 2019 | 299 | 0.600 |
Why?
| | Pneumonia | 2 | 2022 | 600 | 0.580 |
Why?
| | Gene Deletion | 1 | 2019 | 369 | 0.580 |
Why?
| | Child | 36 | 2023 | 20636 | 0.570 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.570 |
Why?
| | Imaging, Three-Dimensional | 4 | 2019 | 529 | 0.550 |
Why?
| | Airway Obstruction | 1 | 2019 | 149 | 0.550 |
Why?
| | Virus Diseases | 2 | 2009 | 209 | 0.530 |
Why?
| | Collagen Type VIII | 1 | 2016 | 3 | 0.530 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2016 | 7 | 0.530 |
Why?
| | Collagen Type IV | 1 | 2016 | 22 | 0.530 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2016 | 61 | 0.520 |
Why?
| | Hernias, Diaphragmatic, Congenital | 3 | 2024 | 203 | 0.500 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2015 | 11 | 0.500 |
Why?
| | Veins | 1 | 2016 | 58 | 0.500 |
Why?
| | Male | 50 | 2025 | 62757 | 0.500 |
Why?
| | Microvessels | 1 | 2016 | 79 | 0.480 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 253 | 0.480 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 198 | 0.480 |
Why?
| | Sarcoma | 1 | 2017 | 176 | 0.470 |
Why?
| | Arteriovenous Fistula | 1 | 2014 | 35 | 0.450 |
Why?
| | Female | 44 | 2024 | 68016 | 0.430 |
Why?
| | Hypoxia | 2 | 2019 | 1034 | 0.430 |
Why?
| | Transcription Factors | 3 | 2023 | 1628 | 0.430 |
Why?
| | Autoantigens | 1 | 2016 | 416 | 0.430 |
Why?
| | Nuclear Proteins | 2 | 2010 | 657 | 0.420 |
Why?
| | Lymphangiogenesis | 2 | 2011 | 25 | 0.410 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 2 | 2009 | 6 | 0.400 |
Why?
| | Tomography, X-Ray Computed | 8 | 2022 | 2509 | 0.400 |
Why?
| | ABO Blood-Group System | 2 | 2011 | 39 | 0.400 |
Why?
| | Endothelium, Lymphatic | 3 | 2009 | 12 | 0.400 |
Why?
| | Antibodies, Monoclonal | 3 | 2009 | 1354 | 0.390 |
Why?
| | Complement C4b | 2 | 2013 | 9 | 0.390 |
Why?
| | Sensitivity and Specificity | 6 | 2017 | 1813 | 0.380 |
Why?
| | Heart Neoplasms | 2 | 2022 | 49 | 0.370 |
Why?
| | Diagnosis, Differential | 8 | 2017 | 1408 | 0.360 |
Why?
| | Biomarkers | 8 | 2024 | 3874 | 0.360 |
Why?
| | Erythema | 1 | 2010 | 27 | 0.350 |
Why?
| | Vena Cava, Superior | 1 | 2010 | 22 | 0.350 |
Why?
| | Forkhead Transcription Factors | 3 | 2023 | 181 | 0.340 |
Why?
| | Phosphoproteins | 2 | 2018 | 328 | 0.340 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1175 | 0.340 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2010 | 36 | 0.340 |
Why?
| | Vena Cava, Inferior | 1 | 2010 | 67 | 0.330 |
Why?
| | Scalp | 2 | 2010 | 34 | 0.330 |
Why?
| | Ranula | 1 | 2009 | 3 | 0.320 |
Why?
| | Mucocele | 1 | 2009 | 12 | 0.320 |
Why?
| | Pleural Effusion | 2 | 2021 | 49 | 0.320 |
Why?
| | Blood Group Antigens | 1 | 2009 | 16 | 0.310 |
Why?
| | Pathology | 1 | 2009 | 22 | 0.310 |
Why?
| | Asthma | 2 | 2021 | 2212 | 0.310 |
Why?
| | Hemodynamics | 5 | 2021 | 1077 | 0.310 |
Why?
| | Vascular Malformations | 1 | 2009 | 50 | 0.300 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 2 | 2021 | 43 | 0.300 |
Why?
| | Adolescent | 17 | 2025 | 20158 | 0.300 |
Why?
| | Cryopreservation | 1 | 2009 | 97 | 0.290 |
Why?
| | Viruses | 1 | 2009 | 99 | 0.290 |
Why?
| | Peptide Fragments | 2 | 2013 | 688 | 0.290 |
Why?
| | Endocardium | 1 | 2007 | 33 | 0.280 |
Why?
| | Phenotype | 5 | 2023 | 3039 | 0.280 |
Why?
| | Heart Transplantation | 3 | 2013 | 711 | 0.280 |
Why?
| | Hemorrhage | 2 | 2021 | 643 | 0.270 |
Why?
| | Infant, Premature | 3 | 2023 | 536 | 0.260 |
Why?
| | Heart Ventricles | 4 | 2022 | 765 | 0.250 |
Why?
| | Temporal Muscle | 1 | 2005 | 3 | 0.250 |
Why?
| | Biopsy | 9 | 2024 | 1077 | 0.250 |
Why?
| | Vascular Resistance | 2 | 2019 | 366 | 0.250 |
Why?
| | Young Adult | 7 | 2023 | 12281 | 0.250 |
Why?
| | Herpesvirus 8, Human | 1 | 2006 | 59 | 0.250 |
Why?
| | Choristoma | 1 | 2005 | 21 | 0.250 |
Why?
| | Thyroid Nuclear Factor 1 | 2 | 2019 | 15 | 0.240 |
Why?
| | Neovascularization, Physiologic | 1 | 2007 | 172 | 0.240 |
Why?
| | Lymphatic Vessel Tumors | 1 | 2005 | 1 | 0.240 |
Why?
| | Submandibular Gland | 1 | 2025 | 19 | 0.240 |
Why?
| | Interleukin-5 | 1 | 2025 | 45 | 0.240 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 25 | 0.240 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 371 | 0.240 |
Why?
| | Disease Models, Animal | 6 | 2019 | 3936 | 0.230 |
Why?
| | Hydroxyindoleacetic Acid | 1 | 2024 | 25 | 0.230 |
Why?
| | Microscopy, Phase-Contrast | 2 | 2021 | 15 | 0.230 |
Why?
| | Synchrotrons | 2 | 2021 | 13 | 0.230 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2025 | 754 | 0.220 |
Why?
| | X-Ray Microtomography | 2 | 2021 | 84 | 0.220 |
Why?
| | Soft Tissue Neoplasms | 1 | 2005 | 112 | 0.220 |
Why?
| | Hemangiopericytoma | 1 | 2003 | 5 | 0.210 |
Why?
| | Lung Transplantation | 2 | 2019 | 278 | 0.210 |
Why?
| | Aorta | 2 | 2019 | 408 | 0.210 |
Why?
| | Infant Death | 1 | 2022 | 5 | 0.200 |
Why?
| | Arteriovenous Malformations | 1 | 2022 | 26 | 0.200 |
Why?
| | Severity of Illness Index | 5 | 2018 | 2703 | 0.200 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 51 | 0.200 |
Why?
| | Fibrin | 1 | 2023 | 68 | 0.200 |
Why?
| | Lymphokines | 1 | 2002 | 115 | 0.200 |
Why?
| | Fibroma | 1 | 2022 | 23 | 0.200 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 40 | 0.200 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 40 | 0.190 |
Why?
| | Serotonin | 1 | 2024 | 317 | 0.190 |
Why?
| | Myocardium | 2 | 2017 | 967 | 0.190 |
Why?
| | Antibodies, Viral | 1 | 2006 | 601 | 0.190 |
Why?
| | Cell Proliferation | 4 | 2019 | 2337 | 0.190 |
Why?
| | Consensus | 1 | 2024 | 607 | 0.190 |
Why?
| | Epilepsy | 1 | 2005 | 322 | 0.180 |
Why?
| | Sjogren's Syndrome | 1 | 2021 | 47 | 0.180 |
Why?
| | Protein C | 1 | 2021 | 41 | 0.180 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 20 | 0.180 |
Why?
| | Vascular Remodeling | 2 | 2021 | 181 | 0.180 |
Why?
| | Vasculitis | 1 | 2021 | 59 | 0.170 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 106 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2021 | 148 | 0.160 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 209 | 0.160 |
Why?
| | Pulmonary Heart Disease | 1 | 2019 | 6 | 0.160 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2019 | 18 | 0.160 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| | Chorea | 1 | 2019 | 11 | 0.160 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| | Adult | 9 | 2023 | 35176 | 0.160 |
Why?
| | Mitochondrial Diseases | 1 | 2020 | 88 | 0.160 |
Why?
| | Case-Control Studies | 5 | 2024 | 3324 | 0.160 |
Why?
| | Retrospective Studies | 9 | 2021 | 14404 | 0.150 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2018 | 15 | 0.150 |
Why?
| | Pulmonary Eosinophilia | 1 | 2018 | 26 | 0.150 |
Why?
| | Heterozygote | 1 | 2019 | 267 | 0.150 |
Why?
| | Exodeoxyribonucleases | 1 | 2018 | 24 | 0.150 |
Why?
| | DNA Copy Number Variations | 1 | 2019 | 169 | 0.150 |
Why?
| | Catheterization, Swan-Ganz | 1 | 2018 | 8 | 0.150 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2018 | 24 | 0.150 |
Why?
| | Silicosis | 1 | 2018 | 27 | 0.150 |
Why?
| | Stenosis, Pulmonary Artery | 1 | 2018 | 4 | 0.150 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 243 | 0.150 |
Why?
| | Nervous System Malformations | 1 | 2018 | 37 | 0.150 |
Why?
| | Gene Expression | 1 | 2023 | 1454 | 0.150 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 101 | 0.150 |
Why?
| | Histiocytosis | 1 | 2017 | 7 | 0.140 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2018 | 92 | 0.140 |
Why?
| | Mice, Knockout | 1 | 2004 | 2757 | 0.140 |
Why?
| | Macrophages, Alveolar | 2 | 2012 | 375 | 0.140 |
Why?
| | Contracture | 1 | 2017 | 21 | 0.140 |
Why?
| | Early Medical Intervention | 1 | 2018 | 57 | 0.140 |
Why?
| | Heart Failure | 3 | 2021 | 2141 | 0.140 |
Why?
| | Pleurisy | 1 | 2017 | 5 | 0.140 |
Why?
| | Multiple Myeloma | 1 | 2019 | 125 | 0.140 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 21 | 0.140 |
Why?
| | Uremia | 1 | 2017 | 13 | 0.140 |
Why?
| | Up-Regulation | 2 | 2020 | 822 | 0.140 |
Why?
| | Coccyx | 1 | 2017 | 5 | 0.140 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 8 | 0.140 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2017 | 56 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2023 | 1105 | 0.140 |
Why?
| | Anti-Asthmatic Agents | 1 | 2021 | 371 | 0.140 |
Why?
| | Developmental Disabilities | 1 | 2020 | 258 | 0.130 |
Why?
| | Arthritis, Juvenile | 1 | 2017 | 53 | 0.130 |
Why?
| | Collagen Type XVIII | 1 | 2016 | 4 | 0.130 |
Why?
| | Syndrome | 2 | 2010 | 332 | 0.130 |
Why?
| | Myocardial Contraction | 1 | 2018 | 333 | 0.130 |
Why?
| | Kidney | 2 | 2022 | 1306 | 0.130 |
Why?
| | Sacrum | 1 | 2017 | 74 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 573 | 0.130 |
Why?
| | Cadaver | 2 | 2015 | 306 | 0.130 |
Why?
| | Teratoma | 1 | 2017 | 103 | 0.130 |
Why?
| | Autopsy | 1 | 2016 | 92 | 0.130 |
Why?
| | Killer Cells, Natural | 1 | 2019 | 426 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 274 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2020 | 730 | 0.120 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 93 | 0.120 |
Why?
| | Cell Transdifferentiation | 1 | 2015 | 30 | 0.120 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2015 | 52 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2003 | 873 | 0.120 |
Why?
| | Marijuana Smoking | 1 | 2018 | 239 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 630 | 0.120 |
Why?
| | Pancreatic Ducts | 1 | 2015 | 79 | 0.120 |
Why?
| | Muscle Proteins | 1 | 2016 | 221 | 0.120 |
Why?
| | Algorithms | 1 | 2022 | 1609 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 229 | 0.110 |
Why?
| | Adventitia | 1 | 2014 | 42 | 0.110 |
Why?
| | Alanine Transaminase | 2 | 2013 | 151 | 0.110 |
Why?
| | Genetic Variation | 1 | 2019 | 933 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 755 | 0.110 |
Why?
| | Pregnancy | 4 | 2019 | 6355 | 0.110 |
Why?
| | Hepatic Veno-Occlusive Disease | 1 | 2013 | 14 | 0.110 |
Why?
| | Macaca fascicularis | 1 | 2013 | 49 | 0.110 |
Why?
| | Radiation Injuries, Experimental | 1 | 2013 | 22 | 0.110 |
Why?
| | I-kappa B Proteins | 1 | 2014 | 73 | 0.110 |
Why?
| | Brain | 1 | 2005 | 2615 | 0.110 |
Why?
| | Adenofibroma | 1 | 2013 | 2 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2016 | 431 | 0.110 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 378 | 0.100 |
Why?
| | Animals | 12 | 2023 | 34487 | 0.100 |
Why?
| | Hyperoxia | 1 | 2014 | 87 | 0.100 |
Why?
| | Infant, Extremely Premature | 1 | 2013 | 60 | 0.100 |
Why?
| | Mucin-5B | 1 | 2015 | 217 | 0.100 |
Why?
| | Gene Expression Profiling | 2 | 2016 | 1681 | 0.100 |
Why?
| | Hepatocytes | 1 | 2013 | 213 | 0.100 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 137 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 624 | 0.100 |
Why?
| | Osteopetrosis | 1 | 2012 | 1 | 0.100 |
Why?
| | Mandibular Neoplasms | 1 | 2012 | 22 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1558 | 0.100 |
Why?
| | Vacuolar Proton-Translocating ATPases | 1 | 2012 | 14 | 0.100 |
Why?
| | Nephrectomy | 1 | 2013 | 158 | 0.100 |
Why?
| | Parasympathetic Nervous System | 1 | 2011 | 27 | 0.090 |
Why?
| | Burkitt Lymphoma | 1 | 2012 | 56 | 0.090 |
Why?
| | Blood Group Incompatibility | 1 | 2011 | 11 | 0.090 |
Why?
| | Glycogen Storage Disease Type III | 1 | 2011 | 1 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 817 | 0.090 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 389 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 68 | 0.090 |
Why?
| | Transplants | 1 | 2011 | 35 | 0.090 |
Why?
| | Lung Injury | 1 | 2014 | 199 | 0.090 |
Why?
| | Prognosis | 4 | 2021 | 3766 | 0.090 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 367 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1921 | 0.090 |
Why?
| | Mannose-Binding Lectins | 1 | 2010 | 10 | 0.090 |
Why?
| | Sympathetic Nervous System | 1 | 2011 | 173 | 0.090 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2010 | 13 | 0.090 |
Why?
| | Antigens, CD1 | 1 | 2010 | 58 | 0.090 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2010 | 3 | 0.090 |
Why?
| | Lectins, C-Type | 1 | 2010 | 69 | 0.090 |
Why?
| | Multiple Organ Failure | 2 | 2012 | 122 | 0.080 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 35 | 0.080 |
Why?
| | MicroRNAs | 1 | 2016 | 674 | 0.080 |
Why?
| | Thyroid Diseases | 1 | 2010 | 35 | 0.080 |
Why?
| | NF-kappa B | 1 | 2014 | 649 | 0.080 |
Why?
| | Reference Values | 1 | 2011 | 776 | 0.080 |
Why?
| | Vascular Stiffness | 1 | 2014 | 463 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 92 | 0.080 |
Why?
| | Islets of Langerhans | 1 | 2015 | 790 | 0.080 |
Why?
| | Time Factors | 4 | 2019 | 6479 | 0.080 |
Why?
| | Tissue Preservation | 1 | 2009 | 11 | 0.080 |
Why?
| | Arthritis, Infectious | 1 | 2010 | 57 | 0.080 |
Why?
| | Antigens, CD34 | 1 | 2009 | 89 | 0.080 |
Why?
| | Disease Management | 1 | 2013 | 583 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1421 | 0.080 |
Why?
| | Ki-67 Antigen | 1 | 2009 | 107 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2011 | 347 | 0.080 |
Why?
| | Sampling Studies | 1 | 2009 | 96 | 0.080 |
Why?
| | Kidney Neoplasms | 1 | 2013 | 349 | 0.080 |
Why?
| | Face | 1 | 2010 | 164 | 0.080 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 120 | 0.080 |
Why?
| | Brain Diseases | 1 | 2010 | 136 | 0.080 |
Why?
| | Hip Joint | 1 | 2010 | 157 | 0.080 |
Why?
| | Papillomaviridae | 1 | 2009 | 113 | 0.070 |
Why?
| | Acute Disease | 1 | 2011 | 961 | 0.070 |
Why?
| | Blood-Air Barrier | 1 | 2008 | 10 | 0.070 |
Why?
| | Adenoviridae | 1 | 2009 | 189 | 0.070 |
Why?
| | Cytomegalovirus | 1 | 2009 | 152 | 0.070 |
Why?
| | Antigens, CD | 1 | 2010 | 481 | 0.070 |
Why?
| | Paraffin Embedding | 1 | 2007 | 28 | 0.070 |
Why?
| | Glucocorticoids | 2 | 2025 | 572 | 0.070 |
Why?
| | Pulmonary Valve | 1 | 2009 | 93 | 0.070 |
Why?
| | Hormones | 1 | 2008 | 140 | 0.070 |
Why?
| | Middle Aged | 5 | 2016 | 30812 | 0.070 |
Why?
| | Wound Healing | 1 | 2009 | 298 | 0.070 |
Why?
| | Lower Extremity | 1 | 2010 | 401 | 0.070 |
Why?
| | Fetal Death | 1 | 2006 | 56 | 0.060 |
Why?
| | Graft Survival | 1 | 2009 | 503 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3009 | 0.060 |
Why?
| | Liver | 1 | 2013 | 1826 | 0.060 |
Why?
| | Sequence Deletion | 2 | 2022 | 178 | 0.060 |
Why?
| | Insulin | 1 | 2015 | 2316 | 0.060 |
Why?
| | Treatment Outcome | 4 | 2025 | 10110 | 0.060 |
Why?
| | Specimen Handling | 1 | 2006 | 163 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2425 | 0.060 |
Why?
| | Rhabdomyosarcoma | 1 | 2005 | 64 | 0.060 |
Why?
| | Fetal Development | 1 | 2008 | 283 | 0.060 |
Why?
| | Neuroglia | 1 | 2005 | 165 | 0.060 |
Why?
| | Fibrosis | 2 | 2017 | 513 | 0.060 |
Why?
| | Sheep | 2 | 2019 | 828 | 0.060 |
Why?
| | Comorbidity | 2 | 2020 | 1537 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2020 | 700 | 0.060 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2004 | 168 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1934 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 230 | 0.050 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2004 | 197 | 0.050 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 65 | 0.050 |
Why?
| | Creatinine | 1 | 2024 | 478 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2022 | 13 | 0.050 |
Why?
| | Mouth Mucosa | 1 | 2022 | 89 | 0.050 |
Why?
| | Mice | 4 | 2014 | 16574 | 0.050 |
Why?
| | Leukemia, Megakaryoblastic, Acute | 1 | 2002 | 10 | 0.050 |
Why?
| | Mosaicism | 1 | 2022 | 71 | 0.050 |
Why?
| | Models, Anatomic | 1 | 2002 | 88 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2003 | 93 | 0.050 |
Why?
| | Myeloproliferative Disorders | 1 | 2002 | 26 | 0.050 |
Why?
| | Plasma Cells | 1 | 2002 | 65 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2019 | 309 | 0.050 |
Why?
| | Lymphoproliferative Disorders | 1 | 2002 | 54 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 377 | 0.040 |
Why?
| | Heparin | 1 | 2002 | 246 | 0.040 |
Why?
| | Surface-Active Agents | 1 | 2021 | 83 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 65 | 0.040 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 192 | 0.040 |
Why?
| | Granuloma | 1 | 2021 | 83 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 129 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2002 | 216 | 0.040 |
Why?
| | Risk Factors | 3 | 2020 | 9696 | 0.040 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2020 | 42 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 499 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 490 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 844 | 0.040 |
Why?
| | Risk Assessment | 1 | 2009 | 3223 | 0.040 |
Why?
| | Tumor Hypoxia | 1 | 2019 | 6 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 597 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 51 | 0.040 |
Why?
| | Coronary Occlusion | 1 | 2019 | 18 | 0.040 |
Why?
| | Signal Transduction | 3 | 2019 | 4812 | 0.040 |
Why?
| | Interleukin-15 | 1 | 2019 | 82 | 0.040 |
Why?
| | Age Factors | 2 | 2016 | 3100 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 192 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 157 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2019 | 116 | 0.040 |
Why?
| | Siblings | 1 | 2019 | 215 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 323 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 45 | 0.040 |
Why?
| | Nucleoside Transport Proteins | 1 | 2017 | 4 | 0.040 |
Why?
| | Tumor Burden | 1 | 2019 | 283 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1199 | 0.040 |
Why?
| | Azathioprine | 1 | 2017 | 49 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2019 | 434 | 0.040 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 108 | 0.040 |
Why?
| | Pyrimidines | 1 | 2021 | 446 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 369 | 0.040 |
Why?
| | Pleura | 1 | 2017 | 22 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 356 | 0.030 |
Why?
| | Prosthesis Failure | 1 | 2018 | 112 | 0.030 |
Why?
| | Risk | 1 | 2020 | 850 | 0.030 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 186 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 494 | 0.030 |
Why?
| | Neurons | 1 | 2005 | 1445 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 17 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2006 | 4853 | 0.030 |
Why?
| | Thoracoscopy | 1 | 2017 | 50 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 55 | 0.030 |
Why?
| | Galectin 3 | 1 | 2016 | 20 | 0.030 |
Why?
| | Prednisone | 1 | 2017 | 230 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2017 | 323 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 580 | 0.030 |
Why?
| | Genetic Markers | 1 | 2017 | 338 | 0.030 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2017 | 117 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 264 | 0.030 |
Why?
| | Methotrexate | 1 | 2017 | 249 | 0.030 |
Why?
| | Radiography | 1 | 2018 | 794 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2018 | 302 | 0.030 |
Why?
| | Heart | 1 | 2020 | 637 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 303 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 801 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 492 | 0.030 |
Why?
| | Neoplasms | 1 | 2010 | 2460 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2015 | 99 | 0.030 |
Why?
| | Disease Progression | 2 | 2019 | 2598 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2015 | 292 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 868 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 620 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 100 | 0.030 |
Why?
| | United States | 3 | 2018 | 13785 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 518 | 0.030 |
Why?
| | North America | 1 | 2015 | 289 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 760 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2015 | 174 | 0.030 |
Why?
| | Elastin | 1 | 2014 | 77 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1482 | 0.030 |
Why?
| | Regeneration | 1 | 2015 | 174 | 0.030 |
Why?
| | Retreatment | 1 | 2013 | 69 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 195 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 108 | 0.030 |
Why?
| | Stents | 1 | 2018 | 504 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 226 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2019 | 881 | 0.030 |
Why?
| | Cohort Studies | 2 | 2018 | 5378 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 76 | 0.030 |
Why?
| | Gene Order | 1 | 2013 | 26 | 0.030 |
Why?
| | Albumins | 1 | 2013 | 101 | 0.030 |
Why?
| | Autoimmunity | 1 | 2019 | 860 | 0.030 |
Why?
| | Liver Failure, Acute | 1 | 2013 | 63 | 0.030 |
Why?
| | Pancreatectomy | 1 | 2015 | 241 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 142 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1690 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1264 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2013 | 115 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2016 | 949 | 0.030 |
Why?
| | Radiation Dosage | 1 | 2013 | 151 | 0.020 |
Why?
| | Gene Dosage | 1 | 2013 | 142 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2013 | 329 | 0.020 |
Why?
| | Collagen | 1 | 2014 | 429 | 0.020 |
Why?
| | Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 3 | 0.020 |
Why?
| | Phenyl Ethers | 1 | 2011 | 4 | 0.020 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 2011 | 12 | 0.020 |
Why?
| | Wilms Tumor | 1 | 2013 | 77 | 0.020 |
Why?
| | S100 Proteins | 1 | 2011 | 36 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 504 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2013 | 228 | 0.020 |
Why?
| | Hemagglutinins | 1 | 2011 | 9 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2541 | 0.020 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 69 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3168 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2012 | 120 | 0.020 |
Why?
| | Isoantibodies | 1 | 2011 | 48 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 165 | 0.020 |
Why?
| | Radiosurgery | 1 | 2013 | 318 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2012 | 269 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 495 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1198 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2010 | 57 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2066 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 1975 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2003 | 2327 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1559 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1828 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 2012 | 238 | 0.020 |
Why?
| | HLA Antigens | 1 | 2011 | 234 | 0.020 |
Why?
| | Shock, Septic | 1 | 2012 | 207 | 0.020 |
Why?
| | Arthralgia | 1 | 2010 | 48 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 930 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2042 | 0.020 |
Why?
| | Monocytes | 1 | 2012 | 546 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1037 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5268 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2820 | 0.020 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2015 | 623 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 608 | 0.020 |
Why?
| | Endocrine System Diseases | 1 | 2007 | 33 | 0.020 |
Why?
| | Growth Disorders | 1 | 2007 | 80 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2007 | 105 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 130 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7035 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2007 | 199 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1984 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2007 | 251 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2508 | 0.010 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 777 | 0.010 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2002 | 14 | 0.010 |
Why?
| | Purpura | 1 | 2002 | 14 | 0.010 |
Why?
| | Karyotyping | 1 | 2002 | 107 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2002 | 80 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 2002 | 159 | 0.010 |
Why?
| | Hyperplasia | 1 | 2002 | 170 | 0.010 |
Why?
| | Bone Marrow | 1 | 2002 | 267 | 0.010 |
Why?
| | Thrombocytopenia | 1 | 2002 | 184 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2002 | 1020 | 0.010 |
Why?
| | RNA, Viral | 1 | 2002 | 615 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2002 | 1140 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3371 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2456 | 0.010 |
Why?
|
|
Galambos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|